Patient Perspectives on a Digital Mobile Health Application for RA
Simran Chahal,1 Norma Biln,1 Bruce Clarke2 1Augurex Life Sciences Corp., Vancouver, British Columbia, Canada; 2B2 Consulting, Kelowna, British Columbia, CanadaCorrespondence: Simran ChahalAugurex Life Sciences, Suite 220 – 887, Great Northern Way, Vancouver, British Columbia, V5T 4T5, Cana...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/67d3e810ce594e54a901333087d98b5d |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Simran Chahal,1 Norma Biln,1 Bruce Clarke2 1Augurex Life Sciences Corp., Vancouver, British Columbia, Canada; 2B2 Consulting, Kelowna, British Columbia, CanadaCorrespondence: Simran ChahalAugurex Life Sciences, Suite 220 – 887, Great Northern Way, Vancouver, British Columbia, V5T 4T5, CanadaTel +1 604-637-3280Email schahal@augurex.comBackground: Emerging evidence suggests that patients are increasingly willing to use digital mobile health applications for rheumatoid arthritis (RA apps). The development and diffusion of RA apps open the possibility of improved management of the disease and better physician–patient interactions. However, adoption rates among apps have been lower than hoped, and research shows that many available RA apps lack key features. There is little research exploring patient preferences for RA apps or patients’ habits and preferences for app payment, which are likely key factors affecting adoption of this technology. This study seeks to understand characteristics of RA patients who have adopted RA apps, their preferences for app features, and their willingness to pay for, and experiences with app payment.Methods: Data for this study come from a 33-question online survey of patients with RA in Canada and the United States (N=30). Information on demographics, diagnosis and management of RA, current use and desired features of RA apps, and prior experience with and willingness to pay for an app was collected. Descriptive statistics are reported, and bivariate analyses (chi-square, point-biserial correlation, and ANOVA) were performed to understand relationships between variables.Results: Respondents showed a clear preference for certain app features, namely symptom tracking, scheduling appointments, and reminders. Physician recommendation for an app and patient tracking of symptoms with an app were significantly related to patient adoption of an RA app. Years since diagnosis with RA, physician recommendation for an RA app, and current use of a non-RA health tracking app were significantly related to patients’ willingness to pay a subscription for an RA app.Conclusion: RA patients appear to prefer task support features in an RA app, notably symptom tracking, appointment scheduling, and reminders, over other features such as those related to dialogue support and social support. The choice of whether an RA app will be free or based on a subscription, pay-per-service, or one-time purchase model may also play a role in eventual adoption. Similarly, physician recommendation appears to influence patients’ decision to use an RA app as well as their willingness to pay a subscription for an app.Keywords: digital health application, adoption, willingness to pay |
|---|